Literature DB >> 25035163

Viral lower respiratory tract infections and preterm infants' healthcare utilisation.

Simon B Drysdale1, Mireia Alcazar-Paris, Theresa Wilson, Melvyn Smith, Mark Zuckerman, Janet L Peacock, Sebastian L Johnston, Anne Greenough.   

Abstract

UNLABELLED: The aim of this study was to determine whether respiratory syncytial virus (RSV) and other viral lower respiratory tract infections (LRTI) in prematurely born infants were associated with similar effects on healthcare utilisation and related cost of care in the second compared to the first year after birth. Thirteen infants who had RSV LRTIs (RSV), 21 who had other viral LRTIs (other viral) and 25 had no viral LRTIs (no LRTI) were prospectively followed. Nasopharyngeal aspirates were collected whenever an infant had an LRTI regardless of whether it was in the hospital or in the community. Healthcare utilisation and the health-related cost of care were determined. Only the RSV group compared to the no LRTI group had higher overall respiratory costs in both year 1 (mean, £3,917 versus £24; p < 0.041) and year 2 (mean, £1,164 versus £61; p = 0.012). Only the RSV group required respiratory admissions; the RSV admission rate in year 2 was 3.4 % (number needed to treat 59).
CONCLUSION: RSV LRTIs are associated with increased healthcare utilisation and cost of care in the first and second year; nevertheless, if prophylaxis is to be cost-effective in the second year, a high risk group needs to be identified.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25035163     DOI: 10.1007/s00431-014-2380-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results.

Authors:  Marcello Lanari; Fulvio Adorni; Michela Silvestri; Alessandra Coscia; Massimo Musicco
Journal:  Early Hum Dev       Date:  2011-01-31       Impact factor: 2.079

2.  Multiple regression of cost data: use of generalised linear models.

Authors:  Julie Barber; Simon Thompson
Journal:  J Health Serv Res Policy       Date:  2004-10

3.  Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

Authors:  Nele Sigurs; Fatma Aljassim; Bengt Kjellman; Paul D Robinson; Fridrik Sigurbergsson; Ragnar Bjarnason; Per M Gustafsson
Journal:  Thorax       Date:  2010-06-27       Impact factor: 9.139

4.  Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors: 
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

5.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

6.  Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.

Authors:  S Broughton; A Roberts; G Fox; E Pollina; M Zuckerman; S Chaudhry; A Greenough
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

7.  School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants.

Authors:  A Greenough; J Alexander; P Boit; J Boorman; S Burgess; A Burke; P A Chetcuti; I Cliff; W Lenney; T Lytle; C Morgan; C Raiman; N J Shaw; K P Sylvester; J Turner
Journal:  Thorax       Date:  2009-02-12       Impact factor: 9.139

8.  Rhinovirus infection and healthcare utilisation in prematurely born infants.

Authors:  Simon B Drysdale; Mireia Alcazar-Paris; Theresa Wilson; Melvyn Smith; Mark Zuckerman; Simon Broughton; Gerrard F Rafferty; Janet L Peacock; Sebastian L Johnston; Anne Greenough
Journal:  Eur Respir J       Date:  2013-04-05       Impact factor: 16.671

9.  Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.

Authors:  J R Groothuis; K M Gutierrez; B A Lauer
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

Review 10.  Lung function prior to viral lower respiratory tract infections in prematurely born infants.

Authors:  Simon B Drysdale; Theresa Wilson; Mireia Alcazar; Simon Broughton; Mark Zuckerman; Melvyn Smith; Gerrard F Rafferty; S L Johnston; Anne Greenough
Journal:  Thorax       Date:  2011-03-28       Impact factor: 9.139

View more
  12 in total

1.  Bedside clinical assessment predicts recurrence after hospitalization due to viral lower respiratory tract infection in young children.

Authors:  Maria Arroyo; Kyle P Salka; Geovanny F Perez; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Gustavo Nino
Journal:  J Investig Med       Date:  2019-12-05       Impact factor: 2.895

2.  TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells.

Authors:  Arij Faksh; Rodney D Britt; Elizabeth R Vogel; Michael A Thompson; Hitesh C Pandya; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

3.  Human metapneumovirus in the preterm neonate: current perspectives.

Authors:  Nathalie L Maitre; John V Williams
Journal:  Res Rep Neonatol       Date:  2016-07-28

4.  Update on current views and advances on RSV infection (Review).

Authors:  Ioannis N Mammas; Simon B Drysdale; Barbara Rath; Maria Theodoridou; Georgia Papaioannou; Alexia Papatheodoropoulou; Eirini Koutsounaki; Chryssie Koutsaftiki; Eleftheria Kozanidou; Vassilis Achtsidis; Paraskevi Korovessi; George P Chrousos; Demetrios A Spandidos
Journal:  Int J Mol Med       Date:  2020-06-15       Impact factor: 4.101

Review 5.  The impact of respiratory viruses on lung health after preterm birth.

Authors:  Nada Townsi; Ingrid A Laing; Graham L Hall; Shannon J Simpson
Journal:  Eur Clin Respir J       Date:  2018-08-01

6.  Hospitalization risk factors for children's lower respiratory tract infection: A population-based, cross-sectional study in Mongolia.

Authors:  Amarjargal Dagvadorj; Erika Ota; Sadequa Shahrook; Purevdorj Baljinnyam Olkhanud; Kenji Takehara; Naoko Hikita; Bayasgalantai Bavuusuren; Rintaro Mori; Takeo Nakayama
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

7.  Use of Medical Resources by Preterm Infants Born at Less than 33 Weeks' Gestation Following Discharge from the Neonatal Intensive Care Unit in Korea.

Authors:  Jang Hoon Lee; Yun Sil Chang
Journal:  J Korean Med Sci       Date:  2015-10-27       Impact factor: 2.153

8.  Current views and advances on Paediatric Virology: An update for paediatric trainees.

Authors:  Ioannis N Mammas; Anne Greenough; Maria Theodoridou; Anna Kramvis; Iliana Christaki; Chryssie Koutsaftiki; Maria Koutsaki; Dimitra M Portaliou; Georgia Kostagianni; Paraskevi Panagopoulou; George Sourvinos; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2015-11-24       Impact factor: 2.447

Review 9.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Authors:  Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Louis Bont; Paul A Checchia; Brigitte Fauroux; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-09-14

10.  Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis.

Authors:  Steven M Brunwasser; Brittney M Snyder; Amanda J Driscoll; Deshayne B Fell; David A Savitz; Daniel R Feikin; Becky Skidmore; Niranjan Bhat; Louis J Bont; William D Dupont; Pingsheng Wu; Tebeb Gebretsadik; Patrick G Holt; Heather J Zar; Justin R Ortiz; Tina V Hartert
Journal:  Lancet Respir Med       Date:  2020-08       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.